These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 19344276

  • 1. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.
    Wu R, Wang H, Xia X, Zhou H, Liu C, Castro M, Xu Z.
    Antioxid Redox Signal; 2009 Jul; 11(7):1523-34. PubMed ID: 19344276
    [Abstract] [Full Text] [Related]

  • 2. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
    Wang H, Yang B, Qiu L, Yang C, Kramer J, Su Q, Guo Y, Brown RH, Gao G, Xu Z.
    Hum Mol Genet; 2014 Feb 01; 23(3):668-81. PubMed ID: 24108104
    [Abstract] [Full Text] [Related]

  • 3. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.
    Towne C, Raoul C, Schneider BL, Aebischer P.
    Mol Ther; 2008 Jun 01; 16(6):1018-25. PubMed ID: 18414477
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ, Lu YY, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Matsushita T, Hanazono Y, Kume A, Nagatsu T, Ozawa K, Nakano I.
    J Neurosci; 2002 Aug 15; 22(16):6920-8. PubMed ID: 12177190
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi.
    Towne C, Aebischer P.
    Methods Mol Biol; 2009 Aug 15; 555():87-108. PubMed ID: 19495690
    [Abstract] [Full Text] [Related]

  • 9. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
    Xia XG, Zhou H, Zhou S, Yu Y, Wu R, Xu Z.
    J Neurochem; 2005 Jan 15; 92(2):362-7. PubMed ID: 15663483
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.
    Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, Xia X, Shi Y, Zamore PD, Xu Z.
    Aging Cell; 2003 Aug 15; 2(4):209-17. PubMed ID: 12934714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Viral delivery of antioxidant genes as a therapeutic strategy in experimental models of amyotrophic lateral sclerosis.
    Nanou A, Higginbottom A, Valori CF, Wyles M, Ning K, Shaw P, Azzouz M.
    Mol Ther; 2013 Aug 15; 21(8):1486-96. PubMed ID: 23732987
    [Abstract] [Full Text] [Related]

  • 14. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
    Nizzardo M, Simone C, Falcone M, Riboldi G, Rizzo F, Magri F, Bresolin N, Comi GP, Corti S.
    Cell Mol Life Sci; 2012 May 15; 69(10):1641-50. PubMed ID: 22094924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
    Acsadi G, Anguelov RA, Yang H, Toth G, Thomas R, Jani A, Wang Y, Ianakova E, Mohammad S, Lewis RA, Shy ME.
    Hum Gene Ther; 2002 Jun 10; 13(9):1047-59. PubMed ID: 12067438
    [Abstract] [Full Text] [Related]

  • 20. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
    Yamashita T, Chai HL, Teramoto S, Tsuji S, Shimazaki K, Muramatsu S, Kwak S.
    EMBO Mol Med; 2013 Nov 10; 5(11):1710-9. PubMed ID: 24115583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.